海王生物(000078.SZ):終止控制權變更及向特定對象發行股票事項
格隆匯6月6日丨海王生物(000078.SZ)公佈,近日,公司、海王集團及絲紡集團簽署了《<關於深圳市海王生物工程股份有限公司之合作協議書>解除協議》,絲紡集團與海王集團及其一致行動人張思民先生、張鋒先生、王菲女士簽署了《<關於深圳市海王生物工程股份有限公司之股份轉讓協議>及<關於深圳市海王生物工程股份有限公司之表決權放棄協議>解除協議》,公司本次控制權變更事項終止。
鑑於公司控制權變更事項終止,公司於2025年6月6日召開了2025年第三次獨立董事專門會議、第九屆董事局第二十四次會議、第九屆監事會第二十次會議,審議通過了終止向特定對象發行A股股票事項的相關事項,同意終止向特定對象發行A股股票,並簽署股份認購協議的解除協議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.